4.3 Article

Fatty liver is an independent risk factor for the development of Type 2 diabetes in Korean adults

Related references

Note: Only part of the references are listed.
Article Endocrinology & Metabolism

Insulin resistance and whole body energy homeostasis in obese adolescents with fatty liver disease

Gianluca Perseghin et al.

AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2006)

Article Gastroenterology & Hepatology

Long-term follow-up of patients with NAFLD and elevated liver enzymes

Mattias Ekstedt et al.

HEPATOLOGY (2006)

Article Gastroenterology & Hepatology

Lipid metabolism and liver inflammation. I. Hepatic fatty acid uptake: Possible role in steatosis

MW Bradbury

AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2006)

Article Endocrinology & Metabolism

Hepatic enzymes, the metabolic syndrome, and the risk of type 2 diabetes in older men

SG Wannamethee et al.

DIABETES CARE (2005)

Article Gastroenterology & Hepatology

Fatty liver and the metabolic syndrome among Shanghai adults

JG Fan et al.

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2005)

Review Gastroenterology & Hepatology

Treatment strategies in nonalcoholic fatty liver disease

H Tilg et al.

NATURE CLINICAL PRACTICE GASTROENTEROLOGY & HEPATOLOGY (2005)

Article Endocrinology & Metabolism

Insulin resistance, the metabolic syndrome, and nonalcoholic fatty liver disease

F Angelico et al.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2005)

Article Gastroenterology & Hepatology

High prevalence of metabolic complications in patients with non-alcoholic fatty liver disease

I Friis-Liby et al.

SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2004)

Article Gastroenterology & Hepatology

A pilot study of ploglitazone treatment for nonalcoholic steatohepatitis

K Promrat et al.

HEPATOLOGY (2004)

Article Medicine, General & Internal

Metabolic significance of nonalcoholic fatty liver disease in nonobese, nondiabetic adults

HJ Kim et al.

ARCHIVES OF INTERNAL MEDICINE (2004)

Article Gastroenterology & Hepatology

Improved nonalcoholic steatohepatitis after 48 weeks of treatment with the PPAR-γ ligand rosiglitazone

BA Neuschwander-Tetri et al.

HEPATOLOGY (2003)

Article Gastroenterology & Hepatology

Increase in the prevalence of fatty liver in Japan over the past 12 years: analysis of clinical background

S Kojima et al.

JOURNAL OF GASTROENTEROLOGY (2003)

Article Endocrinology & Metabolism

Fatty liver in type 2 diabetes mellitus: relation to regional adiposity, fatty acids, and insulin resistance

DE Kelley et al.

AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2003)

Article Medicine, General & Internal

Serum γ-glutamyltransferase and development of impaired fasting glucose or type 2 diabetes in middle-aged Japanese men

N Nakanishi et al.

JOURNAL OF INTERNAL MEDICINE (2003)

Article Gastroenterology & Hepatology

Non-alcoholic fatty liver syndrome: A hepatic consequence of common metabolic diseases

F Angelico et al.

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2003)

Article Gastroenterology & Hepatology

Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome

G Marchesini et al.

HEPATOLOGY (2003)

Article Public, Environmental & Occupational Health

The association of fatty liver and diabetes risk

M Okamoto et al.

JOURNAL OF EPIDEMIOLOGY (2003)

Article Medicine, General & Internal

Metformin in non-alcoholic steatohepatitis

G Marchesini et al.

LANCET (2001)

Article Endocrinology & Metabolism

Nonalcoholic fatty liver disease - A feature of the metabolic syndrome

G Marchesini et al.

DIABETES (2001)

Article Medicine, General & Internal

Alcohol consumption and risk of type 2 diabetes mellitus among US male physicians

UA Ajani et al.

ARCHIVES OF INTERNAL MEDICINE (2000)